Pfizer (PFE) Other Working Capital Changes (2009 - 2026)
Pfizer (PFE) posted quarterly Other Working Capital Changes of $1.7 billion for Q1 2026, down 9.74% year-over-year from $1.9 billion in Q1 2025, and up 121.04% quarter-over-quarter from -$8.2 billion in Q4 2025.
Pfizer (PFE) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Other Working Capital Changes for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q1 2026.
- In Q4 2010, Other Working Capital Changes fell 90.6% year-over-year to $42.0 million; the TTM figure through Dec 2010 stood at -$19.0 million (down 109.55% YoY), while the FY2010 annual figure was -$19.0 million, down 109.55% from the prior year.
- Other Working Capital Changes advanced to $42.0 million in Q4 2010 per PFE's latest filing, from $31.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $447.0 million in Q4 2009 and bottomed at -$411.0 million in Q3 2010.
- Historically, Other Working Capital Changes has averaged $1.3 billion across 5 years, with a median of $2.8 billion in 2022.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 654.38% — and 2025, when it tumbled 99.4%.
- Pfizer's Other Working Capital Changes stood at $447.0 million in 2009, then sank by 90.6% to $42.0 million in 2010.
- Business Quant data shows PFE's Other Working Capital Changes at $42.0 million in Q4 2010, $31.0 million in Q4 2010, and -$411.0 million in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.61 Bn | 630.85 Bn | 17.26 Bn |
| 2 | AbbVie | 470.09 Bn | 463.53 Bn | 12.70 Bn |
| 3 | Merck | 374.19 Bn | 367.05 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.72 Bn | 295.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.19 Bn | 252.29 Bn | 12.86 Bn |
| 6 | Amgen | 236.77 Bn | 222.78 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.67 Bn | 179.49 Bn | 6.22 Bn |
| 8 | Pfizer | 159.54 Bn | 147.84 Bn | 10.94 Bn |
| 9 | Gsk | 105.97 Bn | 101.81 Bn | 8.24 Bn |
| 10 | Sanofi | 55.16 Bn | 47.78 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 1.82 Bn |
| Jun 28, 2026 | 1.82 Bn |
| Jun 28, 2026 | 1.82 Bn |
| Mar 29, 2026 | 1.73 Bn |
| Mar 29, 2026 | 1.73 Bn |
| Mar 29, 2026 | 1.73 Bn |
| Dec 31, 2025 | -8.23 Bn |
| Dec 31, 2025 | -8.23 Bn |
| Dec 31, 2025 | -8.23 Bn |
| Sep 28, 2025 | 36.00 Mn |
| Sep 28, 2025 | 36.00 Mn |
| Sep 28, 2025 | 36.00 Mn |
| Jun 29, 2025 | 4.99 Bn |
| Jun 29, 2025 | 4.99 Bn |
| Jun 29, 2025 | 4.99 Bn |
| Mar 30, 2025 | 1.92 Bn |
| Mar 30, 2025 | 1.92 Bn |
| Mar 30, 2025 | 1.92 Bn |
| Sep 29, 2024 | 5.99 Bn |
| Sep 29, 2024 | 5.99 Bn |